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0.0007) in matrix-bound bFGF, although this represented lessTGF-b1 stimulates the release of pre-formed bFGF from renal
than 3% of the total bFGF released into the supernatant.proximal tubular cells.
Conclusion. The data presented suggest that the main mecha-Background. It is now clear that the progression of renal
nism by which TGF-b1 stimulates bFGF generation by proxi-disease is closely correlated to the degree of renal interstitial
mal tubular epithelial cells is by stimulation of the secretionfibrosis. We have previously demonstrated that the renal proxi-
of preformed cytokine from within the cells.mal tubular epithelial cell may contribute to the fibrotic re-
sponse by the generation of profibrotic cytokines. Trans-
forming growth factor-b1 (TGF-b1) and basic fibroblast growth
factor (bFGF) are two of a group of profibrotic cytokines that
The progression of renal disease is clearly correlatedhave been associated with the development of renal interstitial
with the degree of renal interstitial fibrosis. Increasingfibrosis. In this study, we have examined the influence of TGF-
b1 on the generation of bFGF by renal tubular epithelial cells. interest has therefore focused on the synthesis and secre-
Methods. HK2 cells were grown to confluence and were tion of cytokines by cortical cells and their role in the
serum deprived and stimulated with recombinant TGF-b1 un- pathogenesis of renal fibrosis. Numerous studies haveder serum-free conditions. Subsequently, supernatant, cell-
demonstrated that the key cytokines involved in the de-associated, intracellular, and matrix-associated bFGF concen-
velopment of renal scarring are transforming growth fac-trations were determined by enzyme-linked immunosorbent
assay (ELISA). bFGF mRNA expression was examined by tor-b1 (TGF-b1) and basic fibroblast growth factor
reverse transcription-polymerase chain reaction (RT-PCR). (bFGF). We and others have previously demonstrated
Results. The exposure of confluent serum-deprived HK2 that epithelial cells of the proximal tubule have the po-cells to TGF-b1 led to a significant increase in bFGF concentra-
tential to contribute to the pathogenesis of renal fibrosistion in the cell culture supernatant. Twenty-four hours follow-
by the production of profibrotic cytokines [1–4].ing the addition of 10 ng/ml TGF-b1, this represented a twofold
increase in bFGF concentration (control, 102 pg/ml, N 5 24, Basic fibroblast growth factor (bFGF) is a single-chain
vs. 202 pg/ml, N 5 19, P 5 0.0001). Despite the increase in nonglycosylated polypeptide with a molecular weight of
bFGF concentration in the supernatant, there was no change
18 kDa. Its biological response is mediated through spe-in the expression of bFGF mRNA following the addition of
cific high-affinity cell surface receptors that possess in-TGF-b1. The addition of 10 ng/ml of TGF-b1 led to a 30%
decrease in the total cell-associated bFGF concentration (con- trinsic tyrosine kinase activity [5]. bFGF is a mitogen for
trol, 8.51 ng/ml, N 5 16, TGF-b1, 6.01 ng/ml, N 5 13, P 5 a broad range of cells, as well as a chemoattractant and
0.0042). This decrease in intracellular bFGF was associated a mediator of cellular differentiation [6]. Numerous stud-with a 15% reduction in anti-bFGF antibody binding to fixed
ies have implicated bFGF in the pathogenesis of renalpermeabilized cells, following the addition of 10 ng/ml of re-
disease. bFGF is mitogenic for both mesangial cells andcombinant TGF-b1 (N 5 9, P 5 0.0007), suggesting that the
mechanism of stimulation of bFGF by TGF-b1 involved the proximal tubular epithelial cells [7, 8] and stimulates
release of preformed bFGF from within the cells. In addition, mesangial cell extracellular matrix production [9]. An
following the addition of TGF-b1, there was a significant dose-
injection of bFGF-neutralizing antibody into mice fol-dependent decrease in the amount of bFGF sequestered in
lowing unilateral nephrectomy attenuates the histologi-the extracellular matrix. At a dose of 10 ng/ml TGF-b, this
represented a greater than sevenfold decrease (N 5 9, P 5 cal manifestations characteristic of compensatory renal
growth [10]. In vivo, an intravenous infusion of bFGF
has been shown to mediate increased mesangial cell pro-Key words: transforming growth factor-b1, basic fibroblast growth fac-
tor, interstitial fibrosis, cytokines, progressive renal disease. liferation and extracellular matrix accumulation follow-
ing a subnephritogenic dose of anti-Thy1.1 antibody [7].Received for publication October 13, 1998
In addition, studies of streptozotocin-induced diabeticand in revised form December 31, 1998
Accepted for publication February 4, 1999 rats also suggest a role for bFGF in the pathogenesis of
diabetic nephropathy [11]. 1999 by the International Society of Nephrology
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The control of bFGF production is complex and may deprived cells with recombinant TGF-b1 at concentra-
occur independently at different levels. Although bFGF tions ranging from 0 to 10 ng/ml for 24 hours or stimula-
synthesis may be regulated at the level of transcription tion with 10 ng/ml TGF-b1 for times up to 96 hours.
or translation, a striking feature of bFGF is that it is To study the dose-dependent effects of TGF-b1, total
mostly an intracellular protein consistent with the lack cellular RNA was isolated 24-hour poststimulation, and
of a consensus signal peptide in its gene [12]. These bFGF mRNA was examined by reverse transcription-
observations suggest that bFGF is released from cells polymerase chain reaction (RT-PCR) amplification as
via a “nontraditional” secretory mechanism, such as in previously described [2]. Similarly, to determine the
response to sublethal cell damage or leakage associated time-dependent effects of TGF-b1, at the defined times
with inflammation and tissue damage. Although bFGF up to 96 hours, total cellular RNA was extracted from
is mainly a cell-associated cytokine, it has been demon- both control and stimulated cells following lysis with 4 m
strated that up to 30% of synthesized bFGF may be guanidine isothiocyanate and centrifugation through 5.7 m
associated with extracellular matrix [13, 14]. bFGF has cesium chloride in 0.1 m ethylenediaminetetraacetic acid
a high affinity toward both cell surface and extracellular (EDTA) [17]. Total RNA was reverse transcribed to
matrix heparan sulfate, and the release of proteoglycan- cDNA with M-MLVe reverse transcriptase (GIBCO
bound bFGF may act as a further level for the control
Life Technologies Ltd., Paisley, UK) using the random
of its biological activity [15, 16].
hexamers method as previously described [18]. Briefly,We have previously demonstrated that proximal tubu-
the reaction mixture contained 1 ml random hexamerslar epithelial cells are potential sources of both TGF-b1
(100 mm; Pharmacia Biosystems Ltd., Milton Keynes,and bFGF [2–4]. Furthermore, stimulation of proximal
UK), 5 ml NTPs (2.5 mm; GIBCO/BRL Life Technolo-tubular cells by bFGF induced the secretion of latent
gies), 2 ml 103 PCR buffer (100 mm Tris/HCl, 500 mmTGF-b1 by stimulating secretion of preformed TGF-b1.
KCl, 15 mm MgCl2, and 0.01% wt/vol gelatin), 2 ml dithi-This was not related to the induction of either TGF-b1
othreitol (0.1 m; GIBCO/BRL Life Technologies),gene expression or mRNA translation. The aim of this
1 ml RNAase inhibitor (Promega, Southampton, UK),study was to examine the effect of TGF-b1 on the pro-
1 ml M-MLVe Superscript reverse transcriptase (200duction of bFGF by proximal tubular cells at both the
units; GIBCO/BRL Life Technologies), and 1 mg ofintracellular and pericellular levels.
total RNA.
Polymerase chain reaction amplification was per-
METHODS
formed in a total volume of 50 ml (2 ml of reverse tran-
Cell culture scription product and 48 ml of master mix [36.25 ml H2O,
Initial experiments to determine the effect of TGF- 1.25 ml 59-primer (20 mm), 1.25 ml 39-primer (20 mm), 4 ml
b1 on bFGF generation were performed using primary NTPs, 5 ml 103 PCR buffer, and 0.25 ml Taq polymerase
cultures of human renal proximal tubular cells as pre- (2.5 U, Amplitaq; Applied Biosystems Ltd., War-
viously described [2]. Cells were grown to confluence rington, UK) using a Perkin Elmer 480 Thermocycler
and were serum deprived for 48 hours. Growth-arrested (Applied Biosystems)]. The PCR protocol for bFGF
cells were subsequently stimulated with recombinant mRNA and a-actin was as follows: first cycle, 728C for
TGF-b1 (R&D Systems, Oxford, UK) at concentrations 10 minutes; second cycle, 948C for three minutes and
ranging from 0 to 20 ng/ml under serum-free conditions. 558C for one minute and 728C for one minute; third
Subsequently, to determine the mechanisms involved through 38th cycles, 948C for 40 seconds and 558C for
in TGF-b1-induced bFGF generation, HK2 cells (HPV16- one minute and 728C for one minute. The final cycle was
transformed human renal proximal tubular epithelial
948C for one minute and 608C for 10 minutes. a-Actin
cells) were cultured in Dulbecco’s modified Eagle’s me-
PCR was performed for 28 cycles and bFGF for 36 cycles.dium (DMEM)/Ham’s F12 (Life Technologies, Paisley,
One tenth of the PCR reaction from both the test andUK) supplemented with 10% fetal calf serum (FCS; Bio-
control (a-actin) product was mixed and separated bylogical Industries Ltd., Cumbernauld, UK), glutamine
flat bed electrophoresis in 3% wt/vol NuSieve GTG aga-(Life Technologies), insulin, transferrin, and sodium sel-
rose gels (Flowgen Instruments Ltd., Sittingbourne,enite (Sigma, Poole, UK). Fresh growth medium was
UK), stained with ethidium bromide (Sigma), and photo-added to cells every three to four days until confluent.
graphed. The negatives were scanned using a densitome-Cells were grown to confluency and were growth arrested
ter (Model 620 video densitometer; Bio-Rad Labora-in serum-free medium for 48 hours, and all experiments
tories Ltd., Richmond, CA, USA) and the density of thewere subsequently performed under serum-free condi-
bands compared with those of the housekeeping gene.tions. Experiments were carried out to examine the effect
Results were expressed as bFGF to a-actin ratios normal-of recombinant TGF-b1 on bFGF gene expression and
protein production by either stimulation of serum- ized to the first time point of each experiment.
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Oligonucleotide synthesis N-caproic acid) at 378C for one hour. The bFGF concen-
tration in the cell lysates was subsequently determinedThe sequences of the amplification primers were as
by ELISA.follows: (gene) bFGF, (primers) 59-GGCTTCTTCCT
Following the detachment of the cell monolayer, extra-GCGCATCC-39 and 59-CCGTACTTTGCTTGACCC
cellular matrix laid down by the cells was extracted byG-39, (product size) 283 bp [19]; and (gene) a-actin,
the addition of 4 m guanidine hydrochloride 2% Triton(primers) 59-CCTTCCTGGGCATGGAGTCCT-39 and
X-100 in 25 mm Tris/HCl in the presence of protease59-GGAGCAATGATCTTGATCTT-39, (product size)
inhibitors. To concentrate the bFGF, the resulting ex-204 bp [20].
tract was diluted with phosphate-buffered saline (PBS)In parallel experiments, bFGF protein secretion was
and passed through a Hi-Trap heparin-sepharose columnquantitated by commercial enzyme-linked immunosor-
(Sigma), washed with PBS, and eluted with 3 m sodiumbent assay (ELISA; R&D Systems, Abingdon UK; bFGF
chloride. The elution profile demonstrated that theQuantikine immunoassay, DFB00). Interassay precision
bFGF was eluted in a single peak that was subsequentlyranged from 7.7 to 9.4%, (CV), and intra-assay precision
retained and assayed for bFGF by ELISA.ranged from 3.3 to 5.7% (CV). The assay is sensitive to
To examine the possibility that TGF-b1 displaced ma-1 pg/ml, with no cross-reactivity with a range of other
trix-bound bFGF, HK2 cells were grown to confluencecytokines and growth factors, including TGF-b1. To en-
in T25 tissue culture flasks and were serum deprived.sure that equal numbers of cells were studied in all exper-
Cells were detached from the underlying matrix by theiments, the total cell protein was determined using a
addition of EDTA. TGF-b1 was added to the remainingmicrobicinchonicic acid kit (Pierce-Wariner, Chester,
matrix at a concentration of 10 ng/ml in a total volumeUK). There were no differences in cell protein in any
of 5 ml. Twenty-four hours after the addition of TGF-experiments. All experiments were performed using the
b1, the supernatant was removed, and bFGF was quanti-same volume of medium; therefore, the bFGF results
tated by ELISA.are expressed as an absolute concentration of bFGF.
To examine the potential mechanisms by which bFGF Determination of effect of transforming growth
was released from the cells, HK2 cells were stimulated factor-b1 on intracellular basic fibroblast
with TGF-b1 in the presence or absence of methylamine growth factor concentration
(inhibitor of endocytosis/exocytosis), colchicine, or vin- The effect of TGF-b1 on intracellular bFGF was exam-
blastine (microtubule inhibitors). The toxicity of methyl- ined following the addition of TGF-b1 to serum-deprived
amine, colchicine, and vinblastine was assessed using confluent HK2 cells as previously described [4]. Briefly,
cellular adenosine 59 triphosphate (ATP) measurements cells were treated with TGF-b1 (0 to 10 ng/ml) for 24
as previously described [21]. In addition, cellular ATP hours under serum-free conditions. Subsequently, the
was also determined following the addition of TGF-b1 supernatant was removed, and cells were fixed by treat-
in the absence of the inhibitors. ing the cells with 4% (wt/vol) paraformaldehyde at 48C
The possibility that the TGF-b1–mediated release of for 20 minutes. Following fixation, cells were permeabil-
bFGF may be related to TGF-b1–induced cellular apop- ized by adding permeabilization buffer [PBS, 0.1% bo-
tosis was determined by quantitating apoptosis following vine serum albumin (BSA), 0.1% sodium azide, 0.1%
TGF-b1 stimulation. Cells were seeded in a 96-well plate saponin, pH 7.5] at room temperature for five minutes.
and, once confluent, serum deprived prior to stimulation Fixed, permeabilized cells were incubated with mouse
with TGF-b1 under serum-free conditions (in a total antihuman bFGF antibody (F 6162; Sigma, Poole, UK)
volume of 200 ml) for a further 24 hours. Subsequently, overnight at 48C (at a dilution of 1 in 1000). Subsequently
2 ml of the acridine orange (1 mg/ml) were added to the bound antibody was detected by the addition of alkaline
medium. Apoptotic cells (visible as condensed yellow phosphatase-conjugated antimouse IgG (A 3688; Sigma).
bodies slightly above the plane of the monolayer) were This method allows the qualitative detection of alter-
subsequently counted [22]. ations in intracellular bFGF to be detected, and the re-
sults are expressed as change in the optical density (OD),
Effect of transforming growth factor-b1 on cell- which was measured at 410 nm.
associated and matrix-bound basic fibroblast
growth factor Statistics
Following the stimulation of cells under serum-free For each individual experiment, the mean of duplicate
conditions with TGF-b1 for 24 hours, cells were harvested determinations was calculated. The data are presented
using EDTA and pelleted by centrifugation. Cells were as means 6 sd of N experiments. Statistical analysis
resuspended in lysis buffer (25 mm Tris/HCl, 0.1% Triton between two groups was performed using the unpaired
X-100 with protease inhibitors benzamidine, N-ethyl- Student’s t-test, with a value of P , 0.05 considered to
represent a significant difference.maliamide, phenylmethylsulfonylfluoride, and e-amino-
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mRNA by growth-arrested unstimulated cells. Despite
the increase in bFGF protein concentration in the cell
culture supernatant, there was no significant time- or
dose-dependent alteration in bFGF gene expression fol-
lowing the stimulation of HK2 cells by TGF-b1, as as-
sessed by RT-PCR (Fig. 3).
Effect of transforming growth factor-b1 on cell-
associated basic fibroblast growth factor
Following stimulation of HK2 cells with TGF-b1, there
was a decrease in the total cell-associated bFGF concen-
tration compared with unstimulated cells (Fig. 4).
Twenty-four hours after the addition of 10 ng/ml of
TGF-b1, this represented a 30% decrease in the total
cell-associated bFGF (N 5 13, P 5 0.0042).
Effect of transforming growth factor-b1 on
intracellular basic fibroblast growth
factor concentration
The total cell-associated bFGF concentration repre-
sents both intracellular and cell surface-associated bFGF.
Fig. 1. Effect of transforming growth factor-b1 (TGF-b1) on basic The effect of TGF-b1 on the concentration of intracellu-
fibroblast growth factor (bFGF) secretion by primary cultures of human lar bFGF was determined by assessing the binding of
renal proximal tubular cells. Confluent growth-arrested human renal
anti-bFGF antibody to fixed and permeabilized cellsproximal tubular cells were stimulated with recombinant TGF-b1 (0 to
20 ng/ml) for 24 hours. Supernatant samples were collected, and bFGF stimulated with TGF-b1. Following the addition of
was quantitated by ELISA. Data are means 6 sd, N 5 4; *P , 0.05. TGF-b1 to cells for 24 hours, there was a dose-dependent
reduction in the binding of anti-bFGF antibody to the
cells, suggesting a depletion of preformed bFGF from
intracellular stores (Fig. 5). The decrease in intracellular
RESULTS bFGF manifested as a 15% reduction in anti-bFGF anti-
Effect of transforming growth factor-b1 on basic body binding following the addition of 10 ng/ml of re-
growth factor gene expression and protein secretion combinant TGF-b1 (N 5 9, P 5 0.0007).
The addition of recombinant TGF-b1 to primary cul-
Effect of transforming growth factor-b1 ontures of human renal proximal tubular epithelial cells
extracellular matrix-associated basic
for 24 hours led to an increase in supernatant bFGF fibroblast growth factor
concentration (Fig. 1). At a dose of 10 ng/ml of TGF-
It is postulated that matrix-associated bFGF may serveb1, this represented a 4.3-fold increase in bFGF over
as an extracellular pool of bFGF. We therefore examinedthe control values (10.1 6 4.7 vs. 47.9 6 6 pg/ml, mean 6
the effect of TGF-b1 on extracellular matrix-associatedsd, N 5 4, P 5 0.001).
bFGF. The results demonstrated that extracellular ma-Similarly, an exposure of confluent serum-deprived
trix laid down by unstimulated cultured HK2 cells doesHK2 cells to TGF-b1 led to increased detection of bFGF
contain detectable bFGF after the concentration of ma-
in the cell culture supernatant. This effect was apparent trix samples. In addition, following the addition of
after a 24-hour stimulation period and was significantly TGF-b1, there was a significant dose-dependent de-
increased at doses of TGF-b1 of both 1 (N 5 11, P 5 crease in the amount of bFGF sequestered in the extra-
0.0015) and 10 ng/ml (N 5 19, P 5 0.0001; Fig. 2A). The cellular matrix. At a dose of 10 ng/ml TGF-b, this repre-
stimulation of HK2 cells with 10 ng/ml of TGF-b1 also sented a greater than sevenfold decrease (N 5 9, P 5
led to a time-dependent increase in bFGF, which was 0.0007) in matrix-bound bFGF (Fig. 6). This, however,
maximal at 48 hours after the addition of TGF-b1 only represents a small proportion (less that 3%) of the
(52.56 6 8.09 vs. 233.11 6 21.85 pg/ml, mean 6 sd, total bFGF released following TGF-b1 stimulation.
N 5 4, P 5 0.0001). Subsequently, there was no further The addition of TGF-b to extracellular matrix laid
increase in bFGF concentration (Fig. 2B). down by HK2 cells, following detachment of the cell
Polymerase chain reaction amplification of reverse- monolayer, did not result in any increase in bFGF con-
transcribed HK2 mRNA using specific bFGF primers centration (bFGF concentration in control experiments
resulted in the generation of a single 283 bp bFGF tran- 17.6 6 4.9 pg/ml vs. TGF-b1–treated matrix 19.66 6 17.9,
mean 6 sd, N 5 4, P 5 0.51) This, therefore, excludedscript. There was constitutive expression of bFGF
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the possibility that TGF-b1 displaced bFGF from extra-
cellular matrix.
Mechanisms of release of basic fibroblast growth
factor from tubular epithelial cells
Although the mechanisms of release of bFGF from
intact cells are not clear, it has been suggested that in
other cell systems this may involve a mechanism of exo-
cytosis that could be blocked by methylamine. In con-
trast, the addition of methylamine at doses that have no
effect on cell viability as assessed by measurement of
cellular ATP did not suppress the bFGF release follow-
ing the addition of TGF-b1 to confluent serum-deprived
HK2 cells (Fig. 7).
Further experiments were also performed to deter-
mine the effect of inhibition of microtubule function of
the secretion of bFGF following stimulation by TGF-b1.
In these experiments, microtubule function was inhibited
by the addition of either colchicine or vinblastine. The
addition of either inhibitor in the absence of TGF-b1
led to a dose-dependent increase in bFGF concentration
in the cell culture supernatant, which was accompanied
by a reduction in cellular ATP levels (data not shown).
Therefore, it was not possible to use these inhibitors
to examine the role of microtubule function in bFGF
secretion; however, the results confirm that sublethal cell
injury may be a mechanism of release of bFGF from
proximal tubular cells. In addition, experiments were
performed to determine the effect of inhibition of either
gene transcription using actinomycin D or inhibition of
protein synthesis using cycloheximide as previously de-
scribed [23]. The addition of either inhibitor led to a
dose-dependent decrease in total cellular ATP that was
again accompanied by an increase in supernatant bFGF
concentration (data not shown). As these inhibitors led
to release of bFGF by sublethal cell injury, the contribu-
tion of de novo gene transcription of mRNA translation
could not be evaluated.
To determine the effect of TGF-b1 on cell viability,
confluent HK2 cells were stimulated with TGF-b1 (0 to
10 ng/ml) for 24 hours, and cellular ATP was quantitated.
In contrast to the inhibitors of microtubule function,
gene transcription, and mRNA translation, TGF-b1 did
not reduce cellular ATP [control, 8.6 6 3.1 relative lightFig. 2. Effect of transforming growth factor-b1 (TGF-b1) on basic
fibroblast growth factor (bFGF) secretion by HK2 cells. (A) Serum- units (RLU), N 5 24, 1 ng/ml TGF-b1, 9.55 6 2.88,
deprived HK2 cells were stimulated with TGF-b1 (0 to 10 ng/ml) under N 5 34, 10 ng/ml TGF-b1, 10.67 6 3.2, N 5 34], thusserum-free conditions. Supernatant samples were collected after 24
confirming that the mechanism of TGF-b1 depletion ofhours, and bFGF was quantitated by ELISA. Data are the means 6
sd; for control values N 5 25, 1 ng/ml TGF-b1 N 5 11, and 10 ng/ml intracellular bFGF was not related to cell injury.
TGF-b1 N 5 19; *P , 0.05. (B) Time-dependent effects of TGF-b1 Apoptosis was quantitated by inverted fluorescence
were determined by the addition of 10 ng/ml of TGF-b1 to growth-
microscopy after the addition of acridine orange to se-arrested HK2 cells for up to 96 hours. Supernatant bFGF concentration
was determined by ELISA. Data are means 6 sd, N 5 4; *P , 0.05; rum-deprived cells to which TGF-b1 (10 ng/ml) had been
**P , 0.001. added for 24 hours. Counts of apoptotic cells revealed
that apoptosis was rare and that there was no difference
in the number of apoptotic cells following stimulation
with TGF-b1 and that observed in the control/unstimu-
lated cells.
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Fig. 3. Effect of transforming growth factor-
b1 (TGF-b1) on basic fibroblast growth factor
(bFGF) mRNA expression. Serum-deprived
HK2 cells were either stimulated with TGF-
b1 (0 to 10 ng/ml) in the absence of serum,
and RNA was isolated 24 hours following
stimulation (A) or was stimulated with 10
ng/ml TGF-b1 for up to 96 hours (B). PCR
products were separated by electrophoresis
on a 3% agarose gel. Scanning densitometry
confirmed the lack of induction of bFGF fol-
lowing the addition of TGF-b1. One represen-
tative experiment is shown for both dose- and
time-dependent effects of TGF-b1.
DISCUSSION ies on endothelial cells, it has been demonstrated that
TGF-b1 may modify the production of both proteasesThe results of this study demonstrate that stimulation
and protease inhibitors, which may alter the angiogenicof both primary cultures and transformed proximal tubu-
effects of bFGF in this cell type [23]. These data suggestlar cells with TGF-b1 induced the release of bFGF into
that TGF-b1–stimulated release of bFGF from proximalthe culture supernatant. Furthermore, the increase in
tubule-derived extracellular matrix may be the result ofbFGF was not dependent on an increase in bFGF gene
extracellular matrix remodeling caused by an alterationexpression, as assessed by RT-PCR. The addition of
in proteolytic balance. An alternative possibility is thatTGF-b1 did, however, lead to mobilization of bFGF
TGF-b1 displaced bFGF, because both are known tofrom extracellular matrix, although the magnitude of this
bind heparan sulfate proteoglycans. The data presentedeffect would only account for a small proportion of the
in this study suggest that this does not account for thetotal released bFGF. Although it has been postulated
release of bFGF in our system, as TGF-b1 added tothat bFGF is mainly a cell-associated cytokine, it has
matrix in the absence of a cell monolayer did not inducealso been demonstrated that up to 30% of synthesized
the release of bFGF.bFGF may be associated with extracellular matrix [13,
From the data presented, it appears that the majority14]. bFGF has a high affinity toward both cell surface
of the TGF-b1–induced increase in bFGF concentrationand extracellular matrix heparan sulfate, and the release
involved the release of preformed bFGF from intracellu-of proteoglycan-bound bFGF may act as a further level
lar stores. This is supported by the results demonstratingfor the control of its biological activity [15, 16]. Con-
a decrease in total cell–associated bFGF, and is furthertrolled proteolytic degradation of the extracellular ma-
confirmed by the demonstration of depletion of intracel-trix may therefore represent a mechanism for the control
of the biological activity of matrix-bound bFGF. In stud- lular bFGF following the addition of TGF-b1. While the
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Fig. 5. Effect of transforming growth factor-b1 (TGF-b1) on intracel-
lular basic fibroblast growth factor (bFGF). Serum-deprived HK2 cells
were stimulated with increasing doses of TGF-b1 (0 to 10 ng/ml) under
serum-free conditions. Alterations in intracellular bFGF were deter-
mined by the binding of anti-bFGF antibody to fixed and permeabilizedFig. 4. Decreased cell-associated basic fibroblast growth factor (bFGF)
cells. Bound antibody was detected by incubation with alkaline phospha-concentration following the addition of transforming growth factor-b1
tase-conjugated antimouse antibody (diluted 1/1000 in 0.1% saponin)(TGF-b1). Serum-deprived cells were stimulated with TGF-b1 (0 to 10
at room temperature for one hour. Subsequently, para-nitro-phenyl-ng/ml) for 24 hours under serum-free conditions. Cells were detached
phosphate (pNPP) was added at a concentration of 1 mg/ml in 10%by treatment with ethylenediaminetetraacetic acid and lyzed as de-
(wt/vol) diethanolamine buffer containing 0.5 mm MgCl2, pH 9.8. Colorscribed in the Methods section, and bFGF concentration was deter-
was allowed to develop for one hour, and absorbance was read at 410mined by enzyme-linked immunosorbent assay. Data are the means 6
nm. Results represent the mean OD (410 nm) 6 sd. For control valuessd. For control values N 5 16, 1 ng/ml TGF-b1 N 5 7, and 10 ng/ml
N 5 11, 1 ng/ml TGF-b1 N 5 10, and 10 ng/ml TGF-b1 N 5 9, *P ,TGF-b1 N 5 13, *P , 0.05.
0.05.
mechanism by which bFGF is released from cells has
been detected in the extracellular matrix. Immunohisto-received much attention, no defined mechanism for
chemical studies have revealed that the lectin becomesbFGF release has been described to date. Proposed
concentrated in patches beneath the plasma membrane,mechanisms for bFGF externalization include cell death
which then invaginate, resulting in extracellular vesiclesor damage. Our data demonstrate that the addition of
that contain the lectin [24]. Cooper and Barondes specu-substances that cause sublethal cell injury manifest as a
late that the material released from disrupted extracellu-decrease in cellular ATP levels, and that does lead to a
lar vesicles is then free to bind to the cell surface and/release of bFGF. However, this is unlikely to represent
or the extracellular matrix. Although this novel mecha-a physiologically relevant mode of bFGF release and,
nism for bFGF release is appealing, the possibility is stillfurthermore, it does not provide the mechanism for
speculative.bFGF release following addition of TGF-b1, as there
Our previous studies have suggested that renal proxi-was no alteration in cellular ATP following its addition.
mal tubular cells may play a key role in the initiation ofWe have also demonstrated that bFGF release was not
pathological changes in the renal tubulointerstitium byrelated to TGF-b1 induced apoptosis. In other cell sys-
the production of profibrotic cytokines [23, 25]. Further-tems, it has been proposed that bFGF may be released
more, we have demonstrated that the control of profi-from noninjured cells by a mechanism involving endocy-
brotic cytokine generation involves complex controltosis/exocytosis. In our cell culture system, the lack of
mechanisms that require coordinated stimulation by ainhibition of TGF-b1–stimulated bFGF release using
cytokine network. The addition of 25 mm d-glucosemethylamine argues against this being the mechanism of
caused an increase in TGF-b1 mRNA. TGF-b1 proteinbFGF release from proximal tubular cells. An alternative
synthesis, however, was only seen following the subse-mode of bFGF release has recently been suggested by
quent application of a second stimulus (platelet-derivedwork that examined the export of a lectin from C2 mouse
growth factor or interleukin-1b) [23]. The addition ofmuscle cells by plasma membrane invaginations. This
lectin, like bFGF, lacks a signal sequence and has also either of these second stimuli increased the stability of
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Fig. 7. Methylamine does not affect transforming growth factor-b1Fig. 6. Effect of transforming growth factor-b1 (TGF-b1) on matrix
(TGF-b1)–induced stimulation of basic fibroblast growth factor (bFGF)associated basic fibroblast growth factor (bFGF). Following stimulation
secretion. HK2 cells were stimulated with 10 ng/ml TGF-b1 underof HK2 cells by TGF-b1 (0 to 10 ng/ml) under serum-free conditions
serum-free conditions in the presence of increasing doses of methyl-for 24 hours, cells were detached by treatment with EDTA. The extra-
amine (0 to 20 mm). Supernatant samples were collected after 24 hours,cellular matrix bound to the plates was subsequently extracted using
and bFGF concentration was determined by ELISA. Data presentedguanidine hydrochloride. bFGF in the extracted matrix was concen-
are the means 6 sd; for control values N 5 20, 10 mm and 20 mmtrated using a heparin sepharose column and was subsequently quanti-
methylamine N 5 5.tated by ELISA. Data presented are the means 6 sd; for control values
N 5 8, 1 ng/ml TGF-b1 N 5 8, and 10 ng/ml TGF-b1 N 5 9; *P ,
0.05.
We have demonstrated that in the renal proximal tubu-
lar cell that TGF-b1 is likely to potentiate the activity
d-glucose–induced TGF-b1 mRNA, as assessed by of bFGF. It has been suggested that progressive renal
actinomycin-D chase experiments (abstract; Phillips et interstitial fibrosis may be associated with a persistent
al, J Am Soc Nephrol 6:906, 1995). In contrast, the incu- increase in TGF-b1 expression [28, 29]. It is well estab-
bation of d-glucose–primed cells with tumor necrosis lished that both positive and negative autocrine-feed-
factor-a (TNF-a) did not result in TGF-b1 production, back loops may be involved in the control of cytokine
and unlike interleukin-1b and platelet-derived growth production. These data suggest the existence of such a
factor, TNF-a did not influence TGF-b1 mRNA stability positive feedback loop may therefore be involved in the
[3]. These observations suggest that post-transcriptional pathogenesis of progressive renal injury through the ini-
modification of TGF-b1 mRNA may be limited to spe- tiation and maintenance of synthesis of the profibrotic
cific cytokine stimulation, which may therefore play a cytokines TGF-b1 and bFGF [4].
crucial role in the control of TGF-b1 protein synthesis In conclusion, our study further demonstrates that the
by proximal tubular epithelial cells. Furthermore, we proximal tubular cell, in addition to its role in fluid and
have also demonstrated that exogenously added bFGF electrolyte balance, may influence pathological changes
resulted in the secretion of preformed TGF-b1 [4]. in the renal corticointerstitium by the generation of pro-
Several studies have provided evidence that support fibrotic cytokines. Furthermore, the data suggest that
a role for TGF-b1 in the control of bFGF. Although coordinated activity of the profibrotic cytokine on the
some reports demonstrate that TGF-b1 potentiates the proximal tubular epithelial cell may ultimately lead to
activity of bFGF [26, 27], in other cell systems, these two progressive renal interstitial fibrosis.
growth factors act in an antagonistic manner [23]. It
has therefore been proposed that bFGF and TGF-b1 ACKNOWLEDGMENTS
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